Home / Publication / Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

論文

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

Author(s): Lauren Boak, Craig Rayner, M Lindsay Grayson, David Paterson, Denis Spelman, Sharmila Khumrac, Blair Capitano, Alan Forrest, Jian Li, Roger Nation, Jurgen Bulitta

Year: 2014年2月10日

How Model-informed drug development rescue projects from a risky situation

事例紹介

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

論文

Powered by Translations.com GlobalLink Web Software

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

How Model-informed drug development rescue projects from a risky situation

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

How Model-informed drug development rescue projects from a risky situation​

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

メルマガ登録

クイックアクセス

ソリューション

お問合せ

How Model-informed drug development rescue projects from a risky situation